Jacobs Solutions Inc. - J STOCK NEWS

Jacobs Engineering Group reported robust Q3 2022 results, with revenue of $3.8 billion, a year-over-year increase of 7.0%, and net revenue growth of 11% in constant currency. The company's backlog rose to $28.1 billion, reflecting a 10% annual increase. EPS from continuing operations reached $1.52, compared to $0.82 in Q3 2021. Jacobs secured a $3.9 billion contract with NASA, highlighting strong recurring revenue visibility. The company anticipates adjusted EPS of $1.75 to $1.85 for Q4 2022.

Jacobs (NYSE:J) will announce its fiscal Q3 2022 earnings on August 1, 2022, before market open. The company will conduct a conference call at 8:00 a.m. ET to discuss financial results and operational trends. Jacobs generated $14 billion in revenue and employs approximately 55,000 individuals, offering a wide range of services in consulting, technical, scientific, and project delivery for both government and private sectors.

Jacobs has been selected by New South Wales Health Infrastructure as the lead architect for the redevelopment of St George Hospital in Sydney, Australia. The project is estimated at $282 million (AU $411 million) and aims to enhance care for a growing multicultural population. Scheduled for completion in 2025, the new Integrated Ambulatory Care Precinct will consolidate various health services, improving clinical integration. Jacobs has previously managed over $2.45 billion in healthcare projects, showcasing its capability in delivering innovative healthcare solutions.

Jacobs has partnered with Mitie to deliver the new Integrated Asset Care (IAC) framework for Sellafield Ltd, valued at $310 million (£250 million) over five years. This initiative replaces the existing Operation Site Works (OSW) framework, aiming to enhance safety and efficiency at the UK's most complex nuclear site. The scope includes diverse engineering services and project implementation. Jacobs emphasizes the continuity of its OneAIM team, credited for their previous success. This strategic win reflects Jacobs' commitment to improving project delivery in vital infrastructures.

The Board of Directors of Jacobs has declared a quarterly cash dividend of $0.23 per share of common stock, set to be paid on Aug. 26, 2022, to shareholders on record as of July 29, 2022. Jacobs, with $14 billion in revenue and approximately 55,000 employees, provides a wide array of professional services across various sectors, including government and private markets. This dividend reflects the company's commitment to returning income to its shareholders.

Jacobs has been awarded the JSC Engineering, Technology, and Science (JETS) II contract at NASA Johnson Space Center, valued at $3.9 billion over 10 years. The contract includes a five-year base period and options for additional years. Transition begins August 1, 2022. This contract extends a partnership with NASA that began in 2005, with Jacobs providing engineering and scientific services. Jacobs, the largest services contractor for NASA, reported annual revenues of $14 billion and employs over 55,000 people, reinforcing their commitment to advancing space exploration.

SEE (NYSE: SEE) has appointed Kevin Berryman to its Board of Directors, where he will serve on the Audit Committee. Berryman is currently the President and CFO at Jacobs and brings extensive experience from roles at International Flavors & Fragrances and Nestlé. His expertise in consumer-packaged goods is expected to support SEE's transformation and customer engagement initiatives. The company reported sales of $5.5 billion in 2021 and is committed to sustainable packaging solutions.

Jacobs has been selected for a significant project by Norsk Nukleær Dekommisjonering (NND) to decommission Norway's nuclear facilities. This joint venture with Multiconsult Norge AS focuses on two research sites, with an estimated contract value of up to $100 million over six years. The program aims to safely dismantle the Halden and JEEP-II reactors, projected to take 20-25 years and cost about $1.96 billion. This initiative strengthens Jacobs’ position in the European nuclear decommissioning market, projected to be worth $63 billion by 2025.